Main Article Content
Children, Tuberculosis, Iran
Introduction: Reductions in global tuberculosis incidence are considered as one of the End TB Strategy goal. The diagnosis of tuberculosis (TB) in children is challenging due to insufficient specimen material and the scarcity of bacilli in specimens. The purpose of this study was to evaluate the prevalence, characteristics, clinical profiles, laboratory findings and treatment outcomes of children infected with TB in an Iranian referral hospital during a 10-years period.
Methods: This study was a retrospective analysis of the medical records of 90 children (£15 years) with a diagnosis of tuberculosis who were admitted to Children’s Medical Center Hospital, Tehran, Iran, between March 2006 and March 2016. The patients’ information such as demographic, clinical manifestations, laboratory, radiological and histological tests results, and treatment outcomes were extracted from medical records and were analyzed.
Results: The total prevalence of TB was about 56.6 per 100,000 admitted patients. Most of the patients were between 5 to 12 years. Sixty-one percent were male. Twenty-two percent had the history of TB in their family. Underlying diseases were identified in 30 cases (33%). Thirty-four cases (38%) had pulmonary TB (PTB), 35 cases (39%) had extrapulmonary TB (EPTB), while disseminated TB (DTB) was found in 21 cases (23%). Distribution of DTB in males was higher than in females (36% vs. 6%). In patients < 1 year, DTB was the most frequent type (48 %); however, in patients > 1 year both PTB and EPTB had similar distributions (42%) and were more frequent than DTB (16%).
Conclusions: The total prevalence rate of TB in our study was 56.6 per 100,000 admitted patients. Since the mortality rate was higher in infants, children with DTB and children with underlying diseases, early detection and treatment of these patients will help to reduce the mortality rate of TB disease.
2. Bolursaz MR, Lotfian F, Aghahosseini F, et al. Characteristics of Tuberculosis among Children and Adolescents at a Referral TB’s Hospital, 2006-2011. J Compr Ped 2016;7(3).
3. Cruz AT, Starke JR. A current review of infection control for childhood tuberculosis. Tuberculosis. 2011;91:S11-S15.
4. Khazaei HA, Rezaei N, Bagheri GR, et al. Epidemiology of tuberculosis in the Southeastern Iran. E Eur J Epidemiol. 2005;20(10):879-883.
6. Graham SM, Sismanidis C, Menzies HJ, Marais BJ, Detjen AK, Black RE. Importance of tuberculosis control to address child survival. The Lancet. 2014;383(9928):1605-1607.
7. Perez-Velez CM, Marais BJ. Tuberculosis in children. N Engl J Med. 2012;367(4):348-361.
8. Alavi SM, Salmanzadeh S, Bakhtiyariniya P, Albagi A, Hemmatnia F, Alavi L. Prevalence and treatment outcome of pulmonary and extrapulmonary pediatric tuberculosis in southwestern Iran. Caspian J Intern Med. 2015;6(4):213.
9. Venturini E, Turkova A, Chiappini E, Galli L, de Martino M, Thorne C. Tuberculosis and HIV co-infection in children. BMC Infect Dis. 2014;14(1):1.
10. Wu X-R, Yin Q-Q, Jiao A-X, et al. Pediatric tuberculosis at Beijing children’s hospital: 2002–2010. Pediatrics. 2012;130(6):e1433-e1440.
11. Crump JA, Ramadhani HO, Morrissey AB, et al. Bacteremic disseminated tuberculosis in sub-saharan Africa: a prospective cohort study. Clin Infect Dis. 2012;55(2):242-250.
12. Ghadiri K, Najafi F, Solimani B, et al. Childhood Tuberculosis in Kermanshah, Iran, During 10 Years. Arch Pediatr Infect Dis. 2013;1(3):131-135.
13. Sreeramareddy CT, Ramakrishnareddy N, Shah RK, Baniya R, Swain PK. Clinico-epidemiological profile and diagnostic procedures of pediatric tuberculosis in a tertiary care hospital of western Nepal-a case-series analysis. BMC Pediatr. 2010;10(1):1.
14. Molaeipoor L, Khazaei S, Ayubi E, et al. Epidemiological Investigation of Pediatric Tuberculosis in Tehran Province, 2006-2015. Int J Pediatr. 2016;4(6):1895-1902.
15. Moyo S, Verver S, Mahomed H, et al. Age-related tuberculosis incidence and severity in children under 5 years of age in Cape Town, South Africa. Int J Tuberc Lung Dis. 2010;14(2):149-154.
16. Newton SM, Brent AJ, Anderson S, Whittaker E, Kampmann B. Paediatric tuberculosis. Lancet Infect Dis. 2008;8(8):498-510.
17. Asadi PS, Aghamohammadi A, Mahmoudi S, Pourakbari B, Saboui F, Mamishi S. Clinical, laboratory and imaging findings of the patients with disseminated bacilli Calmette–Guerin disease. Allergol Immunopathol (Madr). 2015;43(3):254-258.
18. Boisson‐Dupuis S, Bustamante J, El‐Baghdadi J, et al. Inherited and acquired immunodeficiencies underlying tuberculosis in childhood. Immunol Rev. 2015;264(1):103-120.
19. Parvaneh N, Pourakbari B, Rezaei N, et al. Impaired in-vitro responses to IL-12 and IFN-in Iranian patients with Mendelian susceptibility to mycobacterial disease. Allergol Immunopathol (Madr).2014.
20. Jain SK, Ordonez A, Kinikar A, et al. Pediatric tuberculosis in young children in India: a prospective study. Biomed Res Int. 2013;2013.
21. Tilahun G, Gebre-Selassie S. Treatment outcomes of childhood tuberculosis in Addis Ababa: a five-year retrospective analysis. BMC Public Health. 2016;16(1):612.
22. Mandalakas AM, Kirchner HL, Walzl G, et al. Optimizing the detection of recent tuberculosis infection in children in a high tuberculosis–HIV burden setting. Am J Respir Crit Care Med. 2015;191(7):820-830.
23. Seddon JA, Hesseling AC, Willemse M, Donald PR, Schaaf HS. Culture-confirmed multidrug-resistant tuberculosis in children: clinical features, treatment, and outcome. Clin Infect Dis. 2012;54(2):157-166.
24. Hailu D, Abegaz WE, Belay M. Childhood tuberculosis and its treatment outcomes in Addis Ababa: a 5-years retrospective study. BMC pediatr. 2014;14(1):1.
25. Lotfian F, Bolursaz MR, Khalilzadeh S, Baghaie N, Hassanzad M, Velayati A. Features of Adolescents Tuberculosis at a Referral TB’s Hospital in Tehran, Iran. Mediterr J Hematol Infect Dis. 2016;8(1).